Differential regulation of CD9 through the CD9 3′UTR was observed across the panel of non-tumorigenic and tumorigenic breast cell lines, with some breast cancer lines showing a high level of activity towards the CD9 3′UTR resulting in low protein expression. The gene discussed is CD9; the disease is breast carcinoma.